Summit Therapeutics Inc. (NASDAQ: SMMT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SUMMIT THERAPEUTICS INC.

Summit Therapeutics Inc. (NASDAQ: SMMT)
Listen to this Section


$15.07
N/A ( 0% ) 10.2K

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Market Data


Open $15.07
Previous Close $15.07
Volume 10.2K
Market Cap $11.70B
Day Range $14.75 - $14.93
52 Week Range $13.83 - $30.98
Shares Outstanding 776.16M
Change % 0%
Net Change N/A
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2015
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 16,248,427.00

Date Type Amount Purchased Purchaser
2025-10-23 Buy 13980789.00 DUGGAN ROBERT W
2025-10-23 Buy 266808.00 Zanganeh Mahkam
2025-10-23 Buy 533617.00 Xia Yu
2025-10-23 Buy 266808.00 Zanganeh Mahkam
2025-10-23 Buy 533617.00 Xia Yu
2025-09-11 Buy 333394.00 DUGGAN ROBERT W
2025-09-11 Buy 333394.00 Zanganeh Mahkam

SEC Filings


Form Type Description Pages Date
8-k 8K-related 19 Nov 07, 2025
4 Insider transactions 1 Oct 23, 2025
4 Insider transactions 1 Oct 23, 2025
4 Insider transactions 1 Oct 23, 2025
4 Insider transactions 1 Oct 23, 2025
4 Insider transactions 1 Oct 23, 2025
8-k 8K-related 15 Oct 22, 2025
8-k 8K-related 66 Oct 20, 2025
10-q Quarterly Reports 63 Oct 20, 2025
4 Insider transactions 1 Sep 19, 2025

Latest News


× Before browsing our site, please accept our cookies policy